gilead sciences facing mounting criticism high price new hepatitis c pill sovaldi offered supply medicine egypt 99 percent discount us price
drug still cost 900 12week course treatment fraction 8400 charged course treatment united states
high price tag america prompted questions us lawmakers friday us health insurers said seeking help state health officials foot bill
gilead said pleased finalized agreement introduction sovaldi egypt highest prevalence rate hepatitis c world
believe sovaldi could major impact public health egypt significantly increasing number people cured hepatitis c gregg alton head corporate medical affairs gilead said emailed statement
egyptian health minister adel eladawi said cairo struck deal usbased gilead government buy sovaldi 300 onemonth box according recent report state news agency mena
would imply cost 900 sovaldi used part 12week drug regimen although cost would higher used 24 weeks also option based different drug combinations
eladawi said gileads offer would apply sovaldi supplies used government clinics adding access programmes would start second half 2014 following completion registration procedures egypt
sovaldi vanguard wave pills could cure liverdestroying disease millions people worldwide even eradicate entirely happen new therapies affordable enough allow widespread use
nowhere problem acute egypt worlds highest prevalence virus following use poorly sterilised needles campaigns dating back 1970s stamp parasitic disease schistosomiasis
like hiv hepatitis c hcv spread blood often via contaminated needles
world health organisation estimates 150 million people worldwide chronically infected developing countries putting risk cirrhosis liver cancer
companies johnson johnson abbvie bristolmyers squibb merck co also developing oral treatment regimens hcv shown dramatic results clinical trials reducing need debilitating interferon injections
doctors industry analysts believe new drugs transform hcv treatment prove hugely profitable developed world tipped become major blockbusters consensus sales forecasts sovaldi alone standing 91 billion 2017 according thomson reuters pharma
risk gulf access patients rich poor parts world causing alarm among health campaigners warn potential rerun battle hiv drugs africa decade ago
medecins du monde nonprofit group provides medical care around world highlighted egypt country dire need new hepatitis c drugs report week
gilead also said plans license sovaldi number indian generic pharmaceutical manufacturers would able sell lowerpriced copies medication
